Generating Patient-Derived Gliomas within Cerebral Organoids
Summary: Glioblastoma (GBM) remains a devastating disease with a median survival of less than two years. Current preclinical models are unable to accurately reflect the complexity of human GBM. We recently established a cerebral organoid glioma (GLICO) model to study the invasion and biology of pati...
Main Authors: | Amanda Linkous, Howard A. Fine |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | STAR Protocols |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666166719300085 |
Similar Items
-
Modeling Patient-Derived Glioblastoma with Cerebral Organoids
by: Amanda Linkous, et al.
Published: (2019-03-01) -
Organoids as a Systems Platform for SCLC Brain Metastasis
by: Vito Quaranta, et al.
Published: (2022-04-01) -
Protocol for generating in vitro glioma models using human-induced pluripotent- or embryonic-stem-cell-derived cerebral organoids
by: Yilin Feng, et al.
Published: (2023-09-01) -
Establishment and validation of glioma patient-derived organoid models
by: Anqi Wang, et al.
Published: (2024-09-01) -
Utility of the Cerebral Organoid Glioma ‘GLICO’ Model for Screening Applications
by: Freya R. Weth, et al.
Published: (2022-12-01)